Alpha Tau Medical (DRTS) EPS (Weighted Average and Diluted) (2021 - 2025)

Alpha Tau Medical has disclosed EPS (Weighted Average and Diluted) across 5 years of filings, most recently posting $0.15 for Q4 2025.

• EPS (Weighted Average and Diluted) for Q4 2025 came in at $0.15, up 11.83% year-over-year; the trailing twelve-month figure through Dec 2025 was $0.15 (up 11.83% YoY), and the FY2025 annual result was -$0.53, down 17.78% from the prior year.
• EPS (Weighted Average and Diluted) came in at $0.15 for Q4 2025 at Alpha Tau Medical, down from $39936.0 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $39936.0 in Q2 2025 to a low of $0.05 in Q4 2022.
• The 5-year median for EPS (Weighted Average and Diluted) is $0.14 (2024), against an average of $10486.4.
• Across the five-year window, EPS (Weighted Average and Diluted) plunged 43.22% in 2022 and soared 98.53% in 2023, its largest moves.
• Alpha Tau Medical's EPS (Weighted Average and Diluted) stood at $0.09 in 2021, then slumped by 43.22% to $0.05 in 2022, then jumped by 98.53% to $0.11 in 2023, then advanced by 27.88% to $0.14 in 2024, then rose by 11.83% to $0.15 in 2025.
• The last three EPS (Weighted Average and Diluted) figures came in at $0.15 (Q4 2025), $39936.0 (Q2 2025), and $0.14 (Q4 2024), per Business Quant data.